resveratrol has been researched along with Carcinoma, Epidermoid in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.00) | 18.2507 |
| 2000's | 9 (18.00) | 29.6817 |
| 2010's | 31 (62.00) | 24.3611 |
| 2020's | 9 (18.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butnariu, M; Chen, JT; Das, T; Dey, A; H Eid, A; Kumar, M; Lopez-Jornet, P; Pentea, M; Pons-Fuster, E; Quispe, C; Sharifi-Rad, J; Umbetova, A; Zam, W | 1 |
| Chen, D; Chen, X; Dong, Z; He, X; Li, J; Li, M; Li, T; Liu, Y; Tao, Y; Wang, Y; Zang, S; Zhao, Z | 1 |
| Fathima, SJ; Jayaraman, S; Patil, S; Raj, AT; Veeraraghavan, VP | 1 |
| Guangjian, Z; Jin, Z; Jizhao, W; Meihe, L; Minchao, K; Rui, Z; Shan, G | 1 |
| Amelio, AL; Eizuka, K; Endo-Sakamoto, Y; Fukamachi, M; Hayashi, F; Iyoda, M; Kasamatsu, A; Kato-Kase, I; Kita, A; Koike, K; Nakashima, D; Ogawara, K; Saito, T; Sawai, Y; Shiiba, M; Sunohara, M; Takiguchi, Y; Tanzawa, H; Toeda, Y; Uzawa, K; Yamauchi, M | 1 |
| Balan, P; Indrakumar, J; Korrapati, PS; Murali, P | 1 |
| Chen, L; Chen, YG; Qiu, CJ; Wu, JH; Xia, JS | 1 |
| Lari Najafi, M; Zhang, B | 1 |
| Bau, DT; Chang, WS; Chiu, HY; Hsu, YM; Shih, LC; Tsai, CW; Tsai, FJ; Yang, JS | 1 |
| Duan, Y; Wang, Y; Xiao, Y; Yin, X | 1 |
| Chung, IK; Kang, HM; Kim, CH; Kim, IR; Kim, SE; Lee, JY; Park, BS; Park, HR; Shin, SH | 1 |
| Hao, Y; Kang, S; Liu, C; Liu, X; Zhang, X | 1 |
| Fushimi, K; Iyoda, M; Kasama, H; Kasamatsu, A; Kouzu, Y; Nakashima, D; Sawai, Y; Shiiba, M; Tanzawa, H; Uzawa, K | 1 |
| Bhatta, AK; Keyal, U; Wang, XL; Zhang, G | 1 |
| Buldak, RJ; Dziedzic, A; Hejmo, T; Hudy, D; Poterala-Hejmo, A; Skonieczna, M | 1 |
| Feng, H; Hao, C; Hao, Y; Huang, W; Li, H; Li, Z; Liao, M; Liu, G; Liu, H; Ning, X; Zhang, G; Zhu, Y | 1 |
| Chiu, JF; Hasenmayer, D; Li, G; Tang, Q; Wei, X; Zhang, D; Zhang, H; Zhang, J | 1 |
| Billack, B; Pietka-Ottlik, M; Pino, MA | 1 |
| Feng, HX; Hao, CG; Hao, YQ; Huang, WX; Li, HG; Li, ZH; Ning, XH; Zhang, GH | 1 |
| Agarwal, C; Agarwal, R; Deep, G; Orlicky, DJ; Sclafani, RA; Shrotriya, S; Tyagi, A; Wang, XJ; Wisell, J | 1 |
| Cheng, ML; Chow, SE; Hsu, CC; Huang, YK; Kao, CH; Liu, YT; Wang, JS; Yang, YW | 1 |
| Bin, Z; Pei-jun, W; Shan, Z; Xiang, W; Yang, G | 1 |
| Atienzar, AN; Camacho-Alonso, F; Lopez-Jornet, P | 1 |
| Krishnan, UM; Mohan, A; Narayanan, S; Sethuraman, S | 1 |
| Bigenzahn, J; Brunner, M; Heiduschka, G; Thurnher, D | 1 |
| Bei, R; Benvenuto, M; Bernardini, R; Di Stefano, E; Fantini, M; Focaccetti, C; Frajese, GV; Izzi, V; Lista, F; Marzocchella, L; Masuelli, L; Mattei, M; Mattera, R; Modesti, A; Sacchetti, P; Tresoldi, I | 1 |
| Lagergren, J; Lin, Y; Lu, Y; Yngve, A | 1 |
| Chen, CT; Chen, MK; Chou, MY; Chuang, YT; Hsieh, YH; Lin, CW; Lin, FY; Tang, CH; Yang, SF | 1 |
| Li, H; Quan, F; Shao, Y; Zhao, Q; Zhao, R | 1 |
| Agarwal, R; Sclafani, RA; Shrotriya, S | 1 |
| Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW; Roomi, NW | 1 |
| Li, HH; Quan, F; Shao, Y; Yao, XB; Zhao, Q; Zhao, RM | 1 |
| Liu, DX; Yang, JL; Yu, XD; Zhang, WL | 1 |
| Chen, XY; Kong, QY; Li, C; Li, H; Liu, J; Wu, ML; Yang, B; Yao, YY; Zhang, P; Zhong, LX | 1 |
| Balasubramanian, G; Krishnan, UM; Mohan, A; Narayanan, S; Sethuraman, S | 1 |
| Ahn, KS; Alharbi, SA; Baek, SH; Chinnathambi, A; Jung, J; Kim, SH; Ko, JH; Kong, M; Lee, H; Lee, J; Lee, JW; Lee, SG; Sethi, G; Shim, BS; Um, JY; Yang, WM; Zayed, ME | 1 |
| George, J; Madan, E; Prasad, S; Roy, P; Shukla, Y | 1 |
| George, J; Hans, RK; Kalra, N; Madan, E; Nigam, N; Prasad, S; Ray, RS; Roy, P; Shukla, Y | 1 |
| Berta, GN; Carlotti, ME; Cavalli, R; Di Carlo, F; Di Scipio, F; Marinos, LM; Salamone, P; Sapino, S; Sprio, AE | 1 |
| Arbesman, J; Athar, M; Back, JH; Bickers, DR; Kim, AL; Kim, KH; Kopelovich, L; Zhu, Y | 1 |
| Amin, AR; Rahman, MA; Shin, DM | 1 |
| Agarwal, C; Agarwal, R; Frederick, B; Gu, M; Sclafani, RA; Siriwardana, S; Takahata, T; Tyagi, A | 1 |
| Brown, J; Le, AD; Lu, QY; Tang, X; Zhang, Q; Zhang, ZF | 1 |
| Athar, M; Bickers, DR; Han, L; Kim, AL; Kopelovich, L; Zhu, H; Zhu, Y | 1 |
| ElAttar, TM; Virji, AS | 1 |
| Babich, H; Reisbaum, AG; Zuckerbraun, HL | 1 |
| Ahmad, N; Katiyar, SK; Mukhtar, H | 1 |
| Adhami, VM; Afaq, F; Ahmad, N; Feyes, DK; Mukhtar, H | 1 |
| Adhami, VM; Afaq, F; Ahmad, N | 1 |
5 review(s) available for resveratrol and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Naturally-Occurring Bioactives in Oral Cancer: Preclinical and Clinical Studies, Bottlenecks and Future Directions.
Topics: Carcinoma, Squamous Cell; Curcumin; Genistein; Humans; Isothiocyanates; Lycopene; Mouth Neoplasms; Phytochemicals; Plant Extracts; Resveratrol; Tea | 2022 |
Present and future perspectives of photodynamic therapy for cutaneous squamous cell carcinoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Fluorouracil; Humans; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Resveratrol; Skin Neoplasms | 2019 |
A perspective on chemoprevention by resveratrol in head and neck squamous cell carcinoma.
Topics: Anticarcinogenic Agents; Carcinoma, Squamous Cell; Chemoprevention; Ethanol; Genetic Predisposition to Disease; Head and Neck Neoplasms; Humans; Resveratrol; Squamous Cell Carcinoma of Head and Neck; Stilbenes | 2015 |
Chemopreventive potential of natural compounds in head and neck cancer.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Catechin; Curcumin; Cyclooxygenase 2 Inhibitors; ErbB Receptors; Head and Neck Neoplasms; Humans; NF-kappa B; Resveratrol; Stilbenes; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2010 |
Antioxidants in chemoprevention of skin cancer.
Topics: Administration, Oral; Administration, Topical; Allyl Compounds; Animals; Anticarcinogenic Agents; Antioxidants; Carcinogens; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cocarcinogenesis; Curcumin; Female; Flavonoids; Humans; Male; Mice; Mice, Inbred SENCAR; Neoplasms, Radiation-Induced; Papilloma; Phenols; Phytotherapy; Plants, Medicinal; Polymers; Reactive Oxygen Species; Resveratrol; Silymarin; Skin Neoplasms; Stilbenes; Sulfides; Tea; Ultraviolet Rays; Zingiber officinale | 2001 |
45 other study(ies) available for resveratrol and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Cellular Hypoxia Mitigation by Dandelion-like Nanoparticles for Synergistic Photodynamic Therapy of Oral Squamous Cell Carcinoma.
Topics: Adenosine Triphosphate; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; ErbB Receptors; Head and Neck Neoplasms; Humans; Hyaluronoglucosaminidase; Hypoxia; Ligands; Micelles; Mouth Neoplasms; Nanogels; Nanoparticles; Oxygen; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Resveratrol; Squamous Cell Carcinoma of Head and Neck | 2022 |
Resveratrol and miR-200c: insights into the prevention of oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; MicroRNAs; Mouth Neoplasms; Resveratrol; Squamous Cell Carcinoma of Head and Neck | 2022 |
Resveratrol improves the cytotoxic effect of CD8 +T cells in the tumor microenvironment by regulating HMMR/Ferroptosis in lung squamous cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Ferroptosis; Humans; Lung; Lung Neoplasms; Resveratrol; Tumor Microenvironment | 2023 |
Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mouth Neoplasms; Phosphorylation; Receptors, Urokinase Plasminogen Activator; Resveratrol; RNA Interference; RNA, Small Interfering; Signal Transduction; Transplantation, Heterologous | 2019 |
Bi-faceted delivery of phytochemicals through chitosan nanoparticles impregnated nanofibers for cancer therapeutics.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Chitosan; Coumaric Acids; Drug Delivery Systems; Drug Liberation; Humans; Nanofibers; Nanoparticles; Neoplasms; Phytochemicals; Polyesters; Reactive Oxygen Species; Resveratrol | 2020 |
Resveratrol inhibits oral squamous cell carcinoma cells proliferation while promoting apoptosis through inhibition of CBX7 protein.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Caspase 9; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Mouth Neoplasms; Polycomb Repressive Complex 1; Resveratrol; Signal Transduction | 2020 |
Resveratrol inhibits skin squamous cell carcinoma proliferation, migration and invasion through up-regulating miR-126.
Topics: Apoptosis; beta Catenin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Neoplasm Invasiveness; Resveratrol; Skin Neoplasms; Transcriptional Activation; Up-Regulation; Wnt Signaling Pathway | 2020 |
Resveratrol inhibited the metastatic behaviors of cisplatin-resistant human oral cancer cells via phosphorylation of ERK/p-38 and suppression of MMP-2/9.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Resveratrol; Squamous Cell Carcinoma of Head and Neck | 2021 |
Resveratrol suppresses malignant progression of oral squamous cell carcinoma cells by inducing the ZNF750/RAC1 signaling pathway.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Progression; Humans; Mouth Neoplasms; rac1 GTP-Binding Protein; Resveratrol; Signal Transduction; Transcription Factors; Tumor Suppressor Proteins | 2021 |
Resveratrol Induces Mitochondrial Apoptosis and Inhibits Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Caspases; Cell Line, Tumor; Cell Movement; Cell Survival; Epithelial-Mesenchymal Transition; Humans; Membrane Potential, Mitochondrial; Resveratrol; Tongue Neoplasms | 2018 |
Resveratrol enhances the effects of ALA-PDT on skin squamous cells A431 through p38/ MAPK signaling pathway.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Humans; MAP Kinase Signaling System; Photochemotherapy; Resveratrol; Skin Neoplasms; Stilbenes | 2018 |
Critical role of deoxynucleotidyl transferase terminal interacting protein 1 in oral cancer.
Topics: Aged; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Carrier Proteins; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Nuclear Proteins; Resveratrol; RNA Interference; Transcription Factors; Xenograft Model Antitumor Assays | 2018 |
Effects of Resveratrol, Berberine and Their Combinations on Reactive Oxygen Species, Survival and Apoptosis in Human Squamous Carcinoma (SCC-25) Cells.
Topics: Antineoplastic Agents; Apoptosis; Berberine; Carcinoma, Squamous Cell; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mouth Neoplasms; Reactive Oxygen Species; Resveratrol; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |
The inhibition of resveratrol to human skin squamous cell carcinoma A431 xenografts in nude mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Body Weight; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Humans; Inhibitor of Apoptosis Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Phytotherapy; Plant Extracts; Repressor Proteins; Resveratrol; RNA, Messenger; Skin Neoplasms; Stilbenes; Survivin; Transplantation, Heterologous; Tumor Suppressor Protein p53; Veratrum | 2013 |
Resveratrol-induced apoptosis is enhanced by inhibition of autophagy in esophageal squamous cell carcinoma.
Topics: Apoptosis; Autophagy; Carcinoma, Squamous Cell; Cell Line, Tumor; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; K562 Cells; Microscopy, Electron, Transmission; Resveratrol; Stilbenes | 2013 |
Ebselen analogues reduce 2-chloroethyl ethyl sulphide toxicity in A-431 cells.
Topics: Antioxidants; Azoles; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Chemical Warfare Agents; Humans; Isoindoles; Mustard Gas; Organoselenium Compounds; Oxidative Stress; Protective Agents; Resveratrol; Stilbenes | 2013 |
[Study of apoptosis related factors regulatory mechanism of resveratrol to human skin squamous cell carcinoma A431 xenograft in nude mice].
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; Female; Humans; Inhibitor of Apoptosis Proteins; Mice; Mice, Nude; Resveratrol; Skin Neoplasms; Stilbenes; Survivin; Xenograft Model Antitumor Assays | 2013 |
Grape seed extract and resveratrol prevent 4-nitroquinoline 1-oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses.
Topics: 4-Nitroquinoline-1-oxide; AMP-Activated Protein Kinases; Animals; Anticarcinogenic Agents; Apoptosis; Carcinogenesis; Carcinogens; Carcinoma, Squamous Cell; Female; Grape Seed Extract; In Situ Nick-End Labeling; Mice; Mice, Inbred C57BL; Resveratrol; Stilbenes; Tongue; Tongue Neoplasms | 2015 |
Resveratrol induced ER expansion and ER caspase-mediated apoptosis in human nasopharyngeal carcinoma cells.
Topics: Anticarcinogenic Agents; Apoptosis; Autophagy; Carcinoma, Squamous Cell; Caspase 12; Caspases; Caspases, Initiator; Cell Line, Tumor; Ceramides; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Humans; Nasopharyngeal Neoplasms; Resveratrol; Stilbenes | 2014 |
Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro.
Topics: Anticarcinogenic Agents; Carcinoma, Squamous Cell; Cell Adhesion; Cell Line, Tumor; Cell Movement; Colorimetry; Humans; Mouth Neoplasms; Neoplasm Invasiveness; Resveratrol; Stilbenes | 2014 |
Effects of resveratrol and irradiation upon oral squamous cell carcinoma cells.
Topics: Anticarcinogenic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; Humans; Mouth Neoplasms; Radiotherapy Dosage; Resveratrol; S Phase; Stilbenes; Time Factors | 2014 |
Novel resveratrol and 5-fluorouracil coencapsulated in PEGylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Fluorouracil; Head and Neck Neoplasms; Humans; Liposomes; Nanoparticles; Polyethylene Glycols; Resveratrol; Squamous Cell Carcinoma of Head and Neck; Stilbenes | 2014 |
Resveratrol synergistically enhances the effect of etoposide in HNSCC cell lines.
Topics: Analysis of Variance; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Flow Cytometry; Head and Neck Neoplasms; Humans; Reference Values; Resveratrol; Squamous Cell Carcinoma of Head and Neck; Stilbenes | 2014 |
Resveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomas.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Proliferation; Curcumin; Drug Synergism; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Phosphorylation; Reactive Oxygen Species; Resveratrol; Salivary Gland Neoplasms; Signal Transduction; Stilbenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
A dietary pattern rich in lignans, quercetin and resveratrol decreases the risk of oesophageal cancer.
Topics: Adenocarcinoma; Aged; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Case-Control Studies; Diet; Esophageal Neoplasms; Esophagus; Feeding Behavior; Female; Humans; Lignans; Logistic Models; Male; Middle Aged; Odds Ratio; Plant Extracts; Quercetin; Resveratrol; Stilbenes | 2014 |
Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Survival; Down-Regulation; Enzyme Activation; Head and Neck Neoplasms; Humans; JNK Mitogen-Activated Protein Kinases; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Resveratrol; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Stilbenes; Tetradecanoylphorbol Acetate; Tongue Neoplasms | 2015 |
[Resveratrol enhances radiosensitivity of human hypopharyngeal carcinoma cell line in nude mice].
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Mice; Mice, Nude; Radiation Tolerance; Radiation-Sensitizing Agents; Resveratrol; Squamous Cell Carcinoma of Head and Neck; Stilbenes; Transplantation, Heterologous; Tumor Burden | 2014 |
In vitro and in vivo inhibition of human Fanconi anemia head and neck squamous carcinoma by a phytonutrient combination.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Curcumin; Dietary Supplements; Disease Models, Animal; Fanconi Anemia; Head and Neck Neoplasms; Humans; Male; Mice; Mice, Nude; Phytochemicals; Phytotherapy; Quercetin; Resveratrol; Squamous Cell Carcinoma of Head and Neck; Stilbenes; Tea; Xenograft Model Antitumor Assays | 2015 |
[The Radiosensitizing Effect of Resveratrol on Hopypharyngeal Carcinoma Cell Line FADU and its Effect on the Cell Cycle].
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Resveratrol; Squamous Cell Carcinoma of Head and Neck; Stilbenes | 2015 |
Resveratrol inhibits oral squamous cell carcinoma through induction of apoptosis and G2/M phase cell cycle arrest.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Mouth Neoplasms; Resveratrol; Stilbenes | 2016 |
PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Proliferation; Cell Survival; Cyclin D1; Female; Gene Expression; HeLa Cells; Humans; Inhibitor of Apoptosis Proteins; Molecular Chaperones; Phosphorylation; Protein Inhibitors of Activated STAT; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-myc; Resveratrol; RNA, Neoplasm; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Survivin; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2015 |
Dual drug loaded nanoliposomal chemotherapy: A promising strategy for treatment of head and neck squamous cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Doxorubicin; Head and Neck Neoplasms; Humans; Liposomes; Nanoparticles; Resveratrol; Stilbenes | 2016 |
Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Head and Neck Neoplasms; Humans; Janus Kinase 1; Janus Kinase 2; Phosphorylation; Radiation-Sensitizing Agents; Resveratrol; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; src-Family Kinases; STAT3 Transcription Factor; Stilbenes; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling Proteins | 2016 |
Regulation of apoptosis by resveratrol through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Squamous Cell; Caspases; Cell Line, Tumor; Humans; Janus Kinases; Membrane Potential, Mitochondrial; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Resveratrol; STAT1 Transcription Factor; Stilbenes; Transcription, Genetic | 2008 |
Resveratrol enhances ultraviolet B-induced cell death through nuclear factor-kappaB pathway in human epidermoid carcinoma A431 cells.
Topics: Antioxidants; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Inhibitor of Apoptosis Proteins; Lim Kinases; Microtubule-Associated Proteins; NF-kappa B; Phosphorylation; Radiation-Sensitizing Agents; Resveratrol; Skin Neoplasms; Stilbenes; Survivin; Ultraviolet Rays | 2009 |
Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by topical application of resveratrol complexed with 2-hydroxypropyl-beta-cyclodextrin.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Anticarcinogenic Agents; beta-Cyclodextrins; Carcinogens; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Transformation, Neoplastic; Cheek; Cricetinae; Drug Combinations; Mesocricetus; Mouth Neoplasms; Pharmaceutical Vehicles; Resveratrol; Stilbenes | 2010 |
Resveratrol targets transforming growth factor-β2 signaling to block UV-induced tumor progression.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Down-Regulation; Female; Humans; Male; Mice; Mice, Hairless; Mice, Inbred C57BL; Mice, Mutant Strains; Resveratrol; Signal Transduction; Skin Neoplasms; Stilbenes; Transforming Growth Factor beta2; Tumor Suppressor Protein p53; Ultraviolet Rays | 2011 |
Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; BRCA1 Protein; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Survival; Cells, Cultured; Comet Assay; DNA Damage; Head and Neck Neoplasms; Histones; Humans; Immunoblotting; Immunohistochemistry; Male; Mice; Mice, Nude; Mutation; Resveratrol; Smad4 Protein; Stilbenes; Transfection; Xenograft Model Antitumor Assays | 2011 |
Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Resveratrol; RNA, Messenger; Stilbenes; Tongue Neoplasms; Transcriptional Activation; Vascular Endothelial Growth Factors | 2005 |
Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways.
Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dimerization; DNA-Binding Proteins; Dose-Response Relationship, Drug; Flavonoids; Gene Expression; Humans; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Protein Binding; Proto-Oncogene Proteins c-jun; Resveratrol; RNA, Messenger; Signal Transduction; Stilbenes; Transcription Factor AP-1 | 2006 |
Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Division; Cisplatin; DNA, Neoplasm; Dose-Response Relationship, Drug; Humans; Indomethacin; Quercetin; Resveratrol; Stilbenes; Tongue Neoplasms; Tumor Cells, Cultured | 1999 |
In vitro response of human gingival epithelial S-G cells to resveratrol.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antioxidants; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Count; Cell Division; Cell Line; Cell Survival; Coloring Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Fibroblasts; Gingiva; Humans; Indicators and Reagents; Keratinocytes; Neutral Red; Oxazines; Resveratrol; Stilbenes; Tongue Neoplasms; Xanthenes | 2000 |
Red wine may reduce oral cancer risks.
Topics: Anticarcinogenic Agents; Carcinoma, Squamous Cell; Cell Division; Humans; Mouth Neoplasms; Quercetin; Resveratrol; Stilbenes; Wine | 2000 |
Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; CDC2-CDC28 Kinases; Cell Division; Cyclin D1; Cyclin D2; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; G1 Phase; Humans; Phosphotransferases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2001 |
Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Proteins; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; G1 Phase; Humans; Resveratrol; Retinoblastoma Protein; Stilbenes; Transcription Factors; Tumor Cells, Cultured | 2001 |